Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 123 clinical trials
featured
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration- CEDAR STUDY

Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration- CEDAR STUDY

  • 1026 views
  • 23 Nov, 2020
  • 1 location
Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration

neovascularization (CNV) associated with age-related macular degeneration (AMD).

fluorescein angiography
angiography
neovascularization
age-related macular degeneration
photodynamic therapy
  • 38 views
  • 07 Nov, 2020
  • 1 location
OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD)

A 2-year phase 3, multicentre, randomised, parallel-group, sham-controlled, double-masked study. Primary efficacy will be determined at Week 52.

  • 0 views
  • 22 Jul, 2021
  • 48 locations
OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD)

A 2-year, phase 3, multicentre, randomised, parallel-group, sham-controlled, double-masked study. Primary efficacy will be determined at Week 52.

  • 0 views
  • 21 Jul, 2021
  • 43 locations
Phase III Study Assessing the Efficacy Safety and Immunogenicity of SOK583A1 Versus Eylea in Patients With Neovascular Age-related Macular Degeneration

Purpose and rationale: To demonstrate similar efficacy, safety and immunogenicity of SOK583A1 and Eylea EU as per Eylea approved treatment regimen in patients with nAMD. The primary clinical question of interest is: Does SOK583A1 have similar efficacy as Eylea EU in terms of mean change in BCVA score in participants …

  • 0 views
  • 17 Jul, 2021
  • 38 locations
Intravitreal Conbercept Injection in Patients With Myopic Choroidal Neovascularization

Choroidal neovascularization (CNV) secondary to pathologic myopia (PM-CNV) is a common vision-threatening complication and often affects adults of working age. Intravitreal injection of any anti

  • 0 views
  • 02 May, 2021
  • 1 location
Treat-and-extend Using Aflibercept for Type 3 Neovascularization

Type 3 neovascularization is a subtype of neovascular age-related macular degeneration (AMD) that is characterized by intraretinal neovascularization. Treat-and-extend (TAE) regimen is a widely

  • 0 views
  • 04 Mar, 2021
  • 1 location
TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular Degeneration

The purpose of the study is to compare photodynamic therapy to transpupillary thermotherapy as a treatment method for choroidal neovascularization in age-related macular degeneration

angiography
macular degeneration
visual loss
neovascularization
fibrosis
  • 19 views
  • 07 Nov, 2020
  • 1 location
601 Versus Ranibizumab in Patients With Pathological Myopic Choroidal Neovascularization (pmCNV)

To evaluate the safety and efficacy of intravitreal recombinant humanized anti-VEGF monoclonal antibody in patients with visual impairment due to pmCNV

  • 0 views
  • 23 Jun, 2021
  • 1 location
Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Central Chorioretinitis

The purpose of this study is to determine the effectiveness of antiangiogenic therapy to choroidal neovascularization secondary to central chorioretinitis.

  • 0 views
  • 16 Feb, 2021
  • 3 locations